Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.

Your heart will not just give you fear and uncertainty after a heart attack; it can leave scar tissue that stiffens your ...

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

Pioneering CRISPR trial shows single infusion permanently lowers bad cholesterol by 50% in patients who don't respond to medication.

A new gene therapy shows promise in controlling cholesterol by lowering bad LDL levels, potentially reducing the risk of ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

For more than a decade, the strongest AIDS drugs could not fully control Matt Chappell's HIV infection. Now his body controls it by itself, and researchers are trying to perfect the gene editing that ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the ...

"Eli Lilly buys Adverum in eye disease gene therapy punt" was originally created and published by Pharmaceutical Technology, ...

An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...